Top Abstract Purchase Related
Home
>
Node
>
Subnode

Biological effects of allogenic leukocytes and leukocyte-depleted blood cell products

Vásová, I.; Mayer, J.

Vnitrni Lekarstvi 41(10): 713-718

1995

ISSN/ISBN: 0042-773X
PMID: 8578706
Document Number: 447627
The use of leukodepleted cellular blood components may reduce some adverse effect of transfusion in certain indications. This review presents the adverse effects of contaminating donor leukocytes in blood components: alloimmunisation, febrile nonhemolytic transfusion reactions, refractoriness to platelet transfusions, graft versus host disease, transmission of leukotropic infections and immunomodulation. The value of leukodepletion in preventing some of these complications, methods of leukodepletion and the current indications of use of leukodepleted components in clinical practice are discussed.

Document emailed within 1 workday
Secure & encrypted payments

Sakamoto, Y.; Wei, L.H.; Buckberg, G.D.; Youg, H.H. 2002: Effects of leukocyte-depleted reoxygenation on endothelial and ventricular function: with observation of a short time period Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 8(6): 343-349
Sawa, Y.; Matsuda, H.; Shimazaki, Y.; Kaneko, M.; Nishimura, M.; Amemiya, A.; Sakai, K.; Nakano, S. 1994: Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting Journal of Thoracic and Cardiovascular Surgery 108(6): 1125-1131
Ogihara, T.; Nakamaru, M.; Higaki, J.; Hata, T.; Kumagai, A.; Kumahara, Y. 1983: A comparison of biological effects of three angiotensin Ii antagonists in sodium depleted hypertensive patients Medical Journal of Osaka University 34(1-2): 21-25
Wautier, J.L. 1991: Blood transfusion and products derived from blood (except platelets and leukocyte concentrates). Immunologic bases and indications La Revue du Praticien 41(23): 2354-2356
Sykes, M. 1989: Suppressive activity in recipients of non-T cell-depleted allogeneic bone marrow transplants: role of T cell-depleted syngeneic marrow Bone Marrow Transplantation 4(Suppl 4): 30-33
Nuchsongsin, F.; Chotivanich, K.; Charunwatthana, P.; Omodeo-Salè, F.; Fausta, O-Salè.; Taramelli, D.; Day, N.P.; White, N.J.; Dondorp, A.M. 2007: Effects of malaria heme products on red blood cell deformability American Journal of Tropical Medicine and Hygiene 77(4): 617-622
Harff, G.A.; Caroline C.Vrijland, A.; Dijkstra, J.B.; Maria J.A. van den Bosch and Jacques P. A.M. Schönberger 2003: Impact of Allogenic Blood Transfusions on Temperature, Platelet Count and Differential Leukocyte Count of Patients after Coronary Artery Bypass Grafting Clinical Laboratory 49(3-4): 143-146
Wojtecka-Lukasik, E.; Maśliński, S. 1992: Fibronectin and fibrinogen degradation products stimulate PMN-leukocyte and mast cell degranulation Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 43(2): 173-181
Hart, J.L.; Sobey, C.G.; Woodman, O.L. 1995: Cholesterol feeding enhances vasoconstrictor effects of products from rabbit polymorphonuclear leukocytes American Journal of Physiology 269(1 Pt 2): H1-H6
1998: Safety of biological products prepared from mammalian cell culture. Detecting viruses in cell banks Developments in Biological Standardization 93: 129
Shalit, M.; Ayalon, M.; Weiss, L.; Leshem, B.; Kedar, E.; Slavin, S. 1986: Bone marrow transplantation with T-cell-depleted grafts. I. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted syngeneic bone marrow grafts Transplantation 42(2): 118-122
Gottlieb, A.A.; Maziarz, G.A.; Tamaki, N.; Sutcliffe, S.B. 1980: The effects of dialyzable products from human leukocyte extracts on cutaneous delayed-hypersensitivity response Journal of Immunology 124(2): 885-892
Vlasova, M.E.; Berezovskaia, I.V.; Petrova, L.I. 1985: Leukocyte enzyme spectrum and the kinetics of the lipid peroxidation products of the blood plasma as a criterion of the severity of poisoning Laboratornoe Delo 12: 713-716
Dreger, P.; Glass, B.; Uharek, L.; Zeis, M.; Schmitz, N. 1997: Allogenic transplantation of mobilized peripheral blood progenitor cells: towards tailored cell therapy International Journal of Hematology 66(1): 1-11
Sundsmo, J.S.; Curd, J.G.; Kolb, W.P.; Müller-Eberhard, H.J. 1978: Leukocyte complement: assembly of the membrane attack complex of complement by human peripheral blood leukocytes in the presence and absence of serum Journal of Immunology 120(3): 855-860
Ruebsaamen, M. 1995: Liability for HIV infection by blood and blood products: A summary of the most important results of the final report of the 3rd fact-finding committee HIV infections by blood and blood products of the 12th German Bundestag AIDS-Forschung 10(6): 305-318
Tchorzewski, H.; Niedworok, J. 1970: Investigations on the response of some lysosomal enzymes of rabbit leukocytes in the course of immunization with allogenic skin graft Acta Physiologica Polonica 21(3): 320-325
1998: Safety of biological products prepared from mammalian cell culture. DNA Developments in Biological Standardization 93: 136-138
Hodge, G.L.; Hodge, S.J.; Nairn, J.; Tippett, E.; Holmes, M.; Reynolds, P.N. 2005: Poststorage leuko-depleted plasma inhibits T-cell proliferation and Th1 response in vitro: characterization of TGFbeta-1 as an important immunomodulatory component in stored blood Transplantation 80(1): 95-101
Zaucha, J.M.; Knopińska-Posłuszny, W.; Lewandowski, K.; Bieniaszewska, M.; Hałaburda, K.; Hellmann, A. 1998: Allogenic blood stem cell transplants: characteristics of transplantation material and clinical transplantation course Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 4(21): 130-133